| Mr Ricky Dean Swearingen, OD OPTOMETRIST | |
|
351 Carlanna Lake Road, Ketchikan, AK 99901 | |
| (907) 225-2020 | |
| (907) 247-2015 |
| Full Name | Mr Ricky Dean Swearingen |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 48 Years |
| Location | 351 Carlanna Lake Road, Ketchikan, Alaska |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245382969 | NPI | - | NPPES |
| OP0074 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 74 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ketchikan Eye Care Center, L.l.c. | 2062302532 | 2 |
News Archive
Skin cells from a patient with an inherited heart disease were the seeds of a stem cell experiment that could help researchers test specific treatments for the disease, known as long QT syndrome. The research results appear in the January 16 issue of the journal Nature.
MannKind Corporation today reported financial results for the fourth quarter and year ended December 31, 2011.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
In new data from a Phase III study in 345 children and adolescents (ages 5-17 years), patients with grass pollen allergic rhinoconjunctivitis treated with Merck's investigational sublingual grass (Phleum Pratense) allergy immunotherapy tablet (AIT) showed a 26 percent greater improvement in the total combined score (daily symptom score and daily medication score), compared to patients receiving placebo
› Verified 2 days ago
| Provider Name | Ketchikan Eye Care Center, L.l.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1255483970 PECOS PAC ID: 2062302532 Enrollment ID: O20040318000165 |
News Archive
Skin cells from a patient with an inherited heart disease were the seeds of a stem cell experiment that could help researchers test specific treatments for the disease, known as long QT syndrome. The research results appear in the January 16 issue of the journal Nature.
MannKind Corporation today reported financial results for the fourth quarter and year ended December 31, 2011.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
In new data from a Phase III study in 345 children and adolescents (ages 5-17 years), patients with grass pollen allergic rhinoconjunctivitis treated with Merck's investigational sublingual grass (Phleum Pratense) allergy immunotherapy tablet (AIT) showed a 26 percent greater improvement in the total combined score (daily symptom score and daily medication score), compared to patients receiving placebo
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Ricky Dean Swearingen, OD OPTOMETRIST 351 Carlanna Lake Road, Ketchikan, AK 99901 Ph: (907) 225-2020 | Mr Ricky Dean Swearingen, OD OPTOMETRIST 351 Carlanna Lake Road, Ketchikan, AK 99901 Ph: (907) 225-2020 |
News Archive
Skin cells from a patient with an inherited heart disease were the seeds of a stem cell experiment that could help researchers test specific treatments for the disease, known as long QT syndrome. The research results appear in the January 16 issue of the journal Nature.
MannKind Corporation today reported financial results for the fourth quarter and year ended December 31, 2011.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
In new data from a Phase III study in 345 children and adolescents (ages 5-17 years), patients with grass pollen allergic rhinoconjunctivitis treated with Merck's investigational sublingual grass (Phleum Pratense) allergy immunotherapy tablet (AIT) showed a 26 percent greater improvement in the total combined score (daily symptom score and daily medication score), compared to patients receiving placebo
› Verified 2 days ago
Prism Eye Associates Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3137 Tongass Ave Ste C, Ketchikan, AK 99901 Phone: 907-885-3999 | |
Ketchikan Eye Care Center, L.l.c. Optometrist Medicare: Medicare Enrolled Practice Location: 351 Carlanna Lake Rd, Ketchikan, AK 99901 Phone: 907-225-2020 Fax: 907-247-2015 | |
Erik D Christianson, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 351 Carlanna Lake Rd, Ketchikan, AK 99901 Phone: 907-225-2020 Fax: 907-247-2015 |